LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
LEQEMBI IQLIK, the lecanemab autoinjector, is now available in the U.S. for initiation of treatment in people with early Alzheimer’s disease. This breakthrough adds a more convenient at-home option to the growing range of Alzheimer’s treatment choices and represents another important step forward in the fight against this devastating disease.
You Have to Ask for a MCI Test
Most doctors won't suggest that you have your memory tested during your annual physical. If you want to know whether your brain is as healthy as the rest of your body, YOU HAVE TO ASK.
We spend our lives scheduling physicals, blood tests, eye exams, and even dental cleanings, yet the most vital organ in our body, the brain, often goes unchecked. Imagine discovering years too late that something could have been done to delay Alzheimer’s, if only you had asked for a simple test.